Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
106,851,987
-
Total 13F shares
-
71,312,542
-
Share change
-
-981,364
-
Total reported value
-
$155,420,766
-
Price per share
-
$2.18
-
Number of holders
-
114
-
Value change
-
-$4,610,056
-
Number of buys
-
62
-
Number of sells
-
50
Institutional Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q2 2025
As of 30 Jun 2025,
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,312,542 shares.
The largest 10 holders included
BlackRock, Inc., CADIAN CAPITAL MANAGEMENT, LP, MORGAN STANLEY, MIRABELLA FINANCIAL SERVICES LLP, VANGUARD GROUP INC, Vitruvian Partners LLP, Mudita Advisors LLP, GEODE CAPITAL MANAGEMENT, LLC, AXA S.A., and STATE STREET CORP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.